Skip to main content
Observe Medical logo

Observe Medical — Investor Relations & Filings

Ticker · OBSRV ISIN · NO0010865009 LEI · 9845005F38B74FFJ1B65 Euronext Expand Manufacturing
Open in API
Filings indexed 643 across all filing types
Latest filing 2024-11-19 Capital/Financing Update
Country NO Norway
Listing Euronext Expand OBSRV

About Observe Medical

https://observemedical.com/

Observe Medical is a medical technology company that develops, markets, and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics. It is building a scalable medtech platform that combines a portfolio of proprietary products with strategic partnerships, leveraging its manufacturing, development, regulatory, and commercial capabilities to bring new technologies to market.

Recent filings

Filing Released Lang Actions
OBSERVE MEDICAL ASA: Approval and publication of prospectus, listing of the tranche 2 private placement shares and launch of subsequent offering
Capital/Financing Update Classification · 98% confidence The document is an announcement by Observe Medical ASA regarding the 'Approval and publication of prospectus, listing of the tranche 2 private placement shares and launch of subsequent offering.' It details the approval of a prospectus by the Norwegian Financial Supervisory Authority (Nw. Finanstilsynet) for a subsequent offering of shares. This activity—announcing the publication of a prospectus and the details of a capital raise/share offering—is directly related to financing activities and the subsequent offering of securities. While it mentions a prospectus (which might suggest IP or LTR), the core action is the announcement of the capital raising mechanism (Subsequent Offering) and the associated regulatory steps (prospectus approval/publication). This fits best under 'Capital/Financing Update' (CAP). It is not a full report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), as it is highly specific to a capital transaction.
2024-11-19 English
Observe Medical ASA: Agreement reached with Convatec to defer payments by 12 months
Capital/Financing Update Classification · 99% confidence The document is a short announcement published on a specific date (19 November, 2024) via a stock exchange mechanism, referencing prior announcements and detailing a specific financial arrangement—the deferral of acquisition consideration payments with Convatec/Unomedical. This type of announcement, which details a material change in financial obligations or corporate agreements outside of standard periodic reports (like 10-K or IR), is typically classified as a general regulatory filing or announcement. Since it specifically concerns a change in payment terms related to an asset transfer, it relates to financing/capital structure changes, but it is not a formal fundraising announcement (CAP). Given its nature as a material, non-periodic disclosure made via a stock exchange, and its brevity (Rule 2 suggests short announcements about material events often fall here), the most appropriate general category is Regulatory Filings (RNS), as it doesn't fit the specific definitions for ER, IR, DIV, or CAP precisely, but is clearly a mandatory market disclosure.
2024-11-19 English
Observe Medical ASA: Agreement reached with Convatec to defer payments by 12 months
Capital/Financing Update Classification · 99% confidence The document is a short announcement dated November 19, 2024, detailing an agreement reached with Convatec to defer payments related to a previous asset transfer. It explicitly mentions that the information is considered 'inside information' pursuant to EU Market Abuse Regulation and is published as a 'stock exchange announcement'. This type of immediate, material, non-financial update that doesn't fit the specific financial report categories (like ER, IR, 10-K) or insider trading (DIRS) is best classified as a general regulatory filing or announcement. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general stock exchange announcement of a material business agreement, especially since it is not a formal report itself (ruling out RPA based on content, though it is an announcement). It is not a CAP (Capital/Financing Update) because it deals with settling existing consideration, not raising new capital, although it impacts working capital. RNS serves as the best fit for general regulatory disclosures.
2024-11-19 English
OBSERVE MEDICAL ASA: Resolutions to increase the share capital in connection with subsequent offering and conditional loan conversion
Capital/Financing Update Classification · 98% confidence The document is an official announcement from Observe Medical ASA detailing resolutions to increase share capital in connection with a subsequent offering and a conditional loan conversion. The core subject matter involves the issuance of new shares, subscription prices, rights offerings, and capital structure changes. This directly aligns with the definition of a Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it focuses specifically on a financing event.
2024-11-18 English
OBSERVE MEDICAL ASA: Resolutions to increase the share capital in connection with subsequent offering and conditional loan conversion
Capital/Financing Update Classification · 98% confidence The document explicitly discusses resolutions to increase the share capital in connection with a 'subsequent offering' and a 'conditional loan conversion'. It details the issuance of new shares ('Offer Shares' and 'Conversion Shares') and subscription prices. This content directly relates to changes in the company's capital structure and fundraising activities. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP). The document is a formal announcement detailing the mechanics of the share issuance, not just a general regulatory filing (RNS) or a report publication announcement (RPA).
2024-11-18 English
Observe Medical ASA: Amendments to loan agreements with Navamedic ASA
Capital/Financing Update Classification · 99% confidence The document is a formal announcement titled "Observe Medical ASA: Amendments to loan agreements with Navamedic ASA." It details specific changes to existing subordinated loan agreements, including principal conversion to shares contingent upon a subsequent offering, and postponement of maturity dates. This type of announcement, which concerns changes to the company's financing structure, debt terms, and capital structure (via share conversion), fits best under the 'Capital/Financing Update' category. It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), but a specific disclosure about financing activities. Therefore, the code CAP is appropriate.
2024-11-15 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.